Pomezia, Italy

Roberto Costante

This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignees: Janssen Biotech, Inc., Protagonist Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roberto Costante. Retrieved from https://idiyas.com/inventor/roberto-costante-ucenawyl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Roberto Costante

Introduction

Roberto Costante is an accomplished inventor based in Pomezia, Italy. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents for inflammatory diseases. His work has the potential to impact the treatment of various health conditions.

Latest Patents

Roberto Costante holds a patent for "Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases." This invention provides novel peptide inhibitors that target the interleukin-23 receptor. The related compositions and methods aim to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Roberto has worked with notable companies in the biotechnology sector. He has been associated with Janssen Biotech, Inc. and Protagonist Therapeutics, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Roberto has collaborated with esteemed colleagues, including Chengzao Sun and Brian Troy Frederick. These partnerships have fostered innovation and have been instrumental in advancing his research initiatives.

Conclusion

Roberto Costante's work exemplifies the spirit of innovation in the field of biomedical research. His contributions, particularly in developing peptide inhibitors for inflammatory diseases, highlight the importance of scientific advancements in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…